First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges
A Rizzo, AD Ricci, G Gadaleta-Caldarola… - Expert Review of …, 2021 - Taylor & Francis
Introduction Immunotherapy has recently taken on an extremely important role in medical
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges
A Rizzo, AD Ricci, G Gadaleta-Caldarola… - EXPERT REVIEW OF …, 2021 - cris.unibo.it
Introduction: Immunotherapy has recently taken on an extremely important role in medical
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges.
A Rizzo, AD Ricci, G Gadaleta-Caldarola… - Expert Review of …, 2021 - europepmc.org
Immunotherapy has recently taken on an extremely important role in medical oncology, as
first-or later-line treatment in several tumor types, and recent years have seen the emerging …
first-or later-line treatment in several tumor types, and recent years have seen the emerging …
[引用][C] First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges
A Rizzo, AD Ricci, G Gadaleta-Caldarola… - Expert Review of …, 2021 - cir.nii.ac.jp
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular
carcinoma: current management and future challenges | CiNii Research CiNii 国立情報学 …
carcinoma: current management and future challenges | CiNii Research CiNii 国立情報学 …
First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges
A Rizzo, AD Ricci… - Expert review of …, 2021 - pubmed.ncbi.nlm.nih.gov
Introduction Immunotherapy has recently taken on an extremely important role in medical
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …
oncology, as first-or later-line treatment in several tumor types, and recent years have seen …